Draxis Receives FDA Approval For Diagnostic Iodine I-131 Capsules

... The radiopharmaceuticalbusiness unit of DRAXIS Health Inc. (TSX: DAX) (NASDAQ: DRAX) has receivedapproval from the U.S. Food and Drug Administration (FDA) regarding itssupplemental new drug application for Sodium Iodide I-131 Capsules USP,Diagnostic - Oral. These diagnostic sodium iodide I-131 capsules are intended to be used byphysicians to perform the radioactive iodide (RAI) uptake test to evaluatethyroid function prior to treatment with stronger therapeutic doses of sodiumiodide I-131... click link for more info. ...